NasdaqCM - Nasdaq Real Time Price • USD
Kiora Pharmaceuticals, Inc. (KPRX)
As of 1:16 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.09 | -0.08 | 0.1 | -0.3 |
| Low Estimate | -0.09 | -0.09 | 0.06 | -0.34 |
| High Estimate | -0.09 | -0.08 | 0.15 | -0.27 |
| Year Ago EPS | -0.79 | -0.89 | -2.69 | 0.1 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 2 |
| Avg. Estimate | -- | -- | 16.5M | 3M |
| Low Estimate | -- | -- | 16M | -- |
| High Estimate | -- | -- | 17.5M | 6M |
| Year Ago Sales | -- | -- | -- | 16.5M |
| Sales Growth (year/est) | -- | -- | -- | -81.80% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.06 | -0.35 | -0.42 | -0.07 |
| EPS Actual | -0.79 | -0.89 | -0.47 | 0.38 |
| Difference | 0.27 | -0.54 | -0.05 | 0.45 |
| Surprise % | 25.50% | -154.30% | -11.90% | 642.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.08 | 0.1 | -0.3 |
| 7 Days Ago | -0.09 | -0.08 | 0.1 | -0.3 |
| 30 Days Ago | -0.08 | -0.08 | -0.07 | -0.28 |
| 60 Days Ago | -0.08 | -0.08 | -0.07 | -0.28 |
| 90 Days Ago | -0.1 | -0.1 | -0.16 | -0.29 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | KPRX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 88.60% | -- | -- | 8.90% |
| Next Qtr. | 91.00% | -- | -- | 11.40% |
| Current Year | 103.70% | -- | -- | 5.70% |
| Next Year | -400.00% | -- | -- | 12.60% |
| Next 5 Years (per annum) | -- | -- | -- | 11.43% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/27/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/9/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/6/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/24/2023 |
Related Tickers
QNRX Quoin Pharmaceuticals, Ltd.
0.7300
0.00%
ENSC Ensysce Biosciences, Inc.
0.5500
+0.88%
PALI Palisade Bio, Inc.
4.5844
-2.25%
NRBO NeuroBo Pharmaceuticals, Inc.
4.0250
+1.13%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.6753
+0.92%
ALGS Aligos Therapeutics, Inc.
0.5500
-4.84%
PXMD PaxMedica, Inc.
0.3000
-9.09%
REVB Revelation Biosciences, Inc.
2.3350
+2.86%
BNOX Bionomics Limited
0.7100
+0.71%
KTTA Pasithea Therapeutics Corp.
5.69
+1.61%